Intuitive Surgical stock analysis: ISRG earns a 95/100 Quality score and 18.5% revenue growth, but a 46.12 P/E keeps the model at Hold.
@2026 – All Right Reserved.
Tag:
stock market
-
-
FeaturedIT ServicesUS Stocks
Accenture Jumps 16% on Its Q4 Beat – and Still Trades at 17 Times Earnings With a 9.3% Free-Cash-Flow Yield
Accenture stock analysis: ACN jumped 16% on its Q4 beat yet trades at 16.96x earnings with a 9.3% FCF yield. Why the model rates it a Buy.
-
Aerospace & DefenseUS Stocks
SpaceX Grows Revenue 91.9% to $23.0 Billion, but a $1.95 Trillion Price Tag Keeps the Model at Hold
Space Exploration Technologies stock analysis: SpaceX grew revenue 91.9% to $23.0B, but a $1.95T valuation and losses keep the model at Hold.
-
BiotechnologyFeaturedUS Stocks
Incyte Grows Revenue 37.7% at a 15.46 P/E – Can It Outrun the 2028 Jakafi Patent Cliff?
Incyte stock analysis: INCY grows revenue 37.7% at a 15.46 P/E with a 98/100 Quality score. Why the model rates it a Buy despite the 2028 Jakafi cliff.
-
Interactive Media & ServicesUS Stocks
Alphabet Looks Cheap at 17 Times Earnings – Until You Strip Out $98 Billion of Investment Gains
Alphabet stock analysis: GOOGL trades at a 17.26 P/E, but $98B of investment gains flatter earnings. Why the model rates Alphabet a Hold.
-
FeaturedPharmaceuticalsUS Stocks
United Therapeutics Rallies on Its Tyvaso IPF Filing – a 95/100 Quality Score at 19.4 Times Earnings
United Therapeutics stock analysis: UTHR rallies on its Tyvaso IPF filing with a 95/100 Quality score and a 19.40 P/E. Why the model rates it a Buy.
-
Food & BeverageUS Stocks
PepsiCo Sinks to a Two-Year Low on a 16.87 P/E and 4.6% Yield – Yet the Model Stops Short of Buy
PepsiCo stock analysis: PEP hits a two-year low on a 16.87 P/E and 4.6% dividend yield. Why leverage and slow growth keep the model at Hold.
Newer Posts